School of Population & Global Health, The University of Western Australia, Perth, Australia.
Western Australian Register of Developmental Anomalies, King Edward Memorial Hospital, Perth, Australia.
Pharmacoepidemiol Drug Saf. 2024 Jun;33(6):e5845. doi: 10.1002/pds.5845.
Medications are commonly used during pregnancy to manage pre-existing conditions and conditions that arise during pregnancy. However, not all medications are safe to use in pregnancy. This study utilized privacy-preserving record linkage (PPRL) to examine medications dispensed under the national Pharmaceutical Benefits Scheme (PBS) to pregnant women in Western Australia (WA) overall and by medication safety category.
In this retrospective, cross-sectional, population-based study, state perinatal records (Midwives Notification Scheme) were linked with national PBS dispensing data using PPRL. Live and stillborn neonates born between 2012 and 2019 in WA were included. The proportion of pregnancies during which the mother was dispensed a PBS medication was calculated, overall and by medication safety category. Factors associated with PBS medication dispensing were examined using logistic regression.
PPRL linkage identified matching records for 97.4% of women with perinatal records. A total of 271 739 pregnancies were identified, with 158 585 (58.4%) pregnancies involving the dispensing of at least one PBS medication. Category A medications (those considered safe in pregnancy) were the most commonly dispensed (n = 119 126, 43.8%) followed by B3 (n = 51 135, 18.8%) and B1 (n = 42 388, 15.6%) medication (those with unknown safety). Over the study period, the dispensing of PBS medications in pregnancy increased (OR: 1.06, 95%CI: 1.06, 1.07). The strongest predictor of medication dispensing in pregnancy was pre-pregnancy dispensing (OR: 3.61, 95%CI: 3.54, 3.68). Other factors associated with medication use in pregnancy were smoking, older maternal age, obesity, and prior pregnancies.
Privacy preserving record linkage provides a way to link cross-jurisdictional data while preserving patient confidentiality and data security. The dispensing of PBS medication in pregnancy was common and increased over time, with approximately 60% of women dispensed at least one medication during pregnancy.
药物在怀孕期间常用于治疗原有疾病和怀孕期间出现的疾病。然而,并非所有药物在怀孕期间都安全使用。本研究利用隐私保护记录链接(PPRL)检查在澳大利亚西部(WA)总体和按药物安全性类别向孕妇配药的国家药品福利计划(PBS)药物。
在这项回顾性、横断面、基于人群的研究中,州围产期记录(助产士通知计划)通过 PPRL 与国家 PBS 配药数据链接。包括 2012 年至 2019 年在 WA 出生的活产和死产新生儿。计算了母亲配药的妊娠比例,总体和按药物安全性类别。使用逻辑回归检查与 PBS 药物配药相关的因素。
PPRL 链接确定了 97.4%具有围产期记录的女性的匹配记录。确定了 271739 例妊娠,其中 158585 例(58.4%)妊娠至少配药一种 PBS 药物。A 类药物(被认为在怀孕期间安全)是最常配药的(n=119126,43.8%),其次是 B3(n=51135,18.8%)和 B1(n=42388,15.6%)药物(安全性未知)。在研究期间,怀孕期间配药 PBS 药物的数量增加(OR:1.06,95%CI:1.06,1.07)。怀孕期间配药的最强预测因素是孕前配药(OR:3.61,95%CI:3.54,3.68)。与怀孕期间用药相关的其他因素包括吸烟、母亲年龄较大、肥胖和既往妊娠。
隐私保护记录链接提供了一种链接跨司法管辖区数据的方法,同时保护患者的机密性和数据安全性。怀孕期间 PBS 药物的配药很常见,并且随着时间的推移而增加,大约 60%的女性在怀孕期间至少配药一种药物。